Related Experiment Video

Updated: Jul 17, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

[Issues addressed by tuberculosis in France in 2003]

Elisabeth Bouvet1

  • 1Service des maladies infectieuses et tropicales, Hôpital Bichat, 46, rue Henri Huchard, 75018 Paris, France. elisabeth.bouvet@bch.ap-hop.paris.fr

Medecine Sciences : M/S
|December 4, 2003
PubMed

Insights

Tuberculosis incidence in France is stable, with a rise in Paris primarily linked to immigration. Effective drug resistance management is noted, but enhanced control strategies are needed.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Context:

  • Tuberculosis (TB) incidence in France has remained stable over the past four years.
  • While national TB rates show a constant decline, the Paris region has experienced a slight increase.
  • This rise in Paris, mirroring trends in other global cities, is largely attributed to immigrant populations.

Purpose:

  • To analyze current tuberculosis trends in France, particularly in the Paris region.
  • To identify key drivers of tuberculosis incidence, including demographic factors and coinfections.
  • To evaluate the effectiveness of current treatment strategies and recommend improvements for tuberculosis control.

Summary:

  • The study highlights a concerning increase in tuberculosis cases within the Paris region, contrasting with a national decline.
  • Immigration is identified as the primary driver for the rise in Parisian TB cases, while HIV coinfection's role is diminishing.
  • Low and stable rates of drug resistance and multidrug resistance suggest satisfactory treatment outcomes for active tuberculosis.

Impact:

  • The findings underscore the need for targeted public health interventions in urban centers like Paris.
  • Implementing enhanced infection control policies, including active contact screening and latent TB treatment, is crucial for future tuberculosis control.
  • Understanding the specific drivers of TB in different regions is essential for effective disease management and prevention strategies.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...